← Leaderboards
Christopher Hourigan
National Heart, Lung, And Blood Institute
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at National Heart, Lung, And Blood Institute
Same institution · by research overlap
Others in their field
Top investigators on “Chemotherapy”
- George R Seage · Abt Associates, Inc.$223,371,661
- Charles A Coltman · Southwest Oncology Group$170,244,220
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Peter C Adamson · National Childhood Cancer Foundation$154,566,243
- Philip J Disaia · University Of California Irvine$115,055,799
- Norman Wolmark · Nsabp Foundation, Inc.$106,367,723
Research focus
ChemotherapyClinical TrialsBiological MarkersImmunotherapyComorbidityDisease RemissionPreventionInterestRelapseSamplingDetectionMedicalAllogenicMyeloproliferative DiseaseLaboratoriesDiagnosisElderlyMolecularPeripheral BloodUnited States National Institutes Of HealthBlood SpecimenBaseTransplantationMeasurable
Grant awards (11)
Detection, prevention and treatment of acute myeloid leukemia (AML) relapse.$2,779,530
ZIA · FY2023 · HL · contact PI
Detection, prevention and treatment of acute myeloid leukemia (AML) relapse.$2,106,043
ZIA · FY2022 · HL · contact PI
Detection, prevention and treatment of acute myeloid leukemia (AML) relapse.$2,344,269
ZIA · FY2021 · HL · contact PI
Detection, prevention and treatment of acute myeloid leukemia (AML) relapse.$1,637,478
ZIA · FY2020 · HL · contact PI
Detection, prevention and treatment of acute myeloid leukemia (AML) relapse.$1,865,407
ZIA · FY2019 · HL · contact PI
Detection, prevention and treatment of acute myeloid leukemia (AML) relapse.$2,079,438
ZIA · FY2018 · HL · contact PI
Detection, prevention and treatment of acute myeloid leukemia (AML) relapse.$1,756,455
ZIA · FY2017 · HL · contact PI
Detection, prevention and treatment of acute myeloid leukemia (AML) relapse.$2,245,745
ZIA · FY2016 · HL · contact PI
Detection, prevention and treatment of acute myeloid leukemia (AML) relapse.$2,117,028
ZIA · FY2015 · HL · contact PI
Detection, prevention and treatment of acute myeloid leukemia (AML) relapse.$1,231,558
ZIA · FY2014 · HL · contact PI
Detection, prevention and treatment of acute myeloid leukemia (AML) relapse.$808,122
ZIA · FY2013 · HL · contact PI